• CAS No.：
  1849616-42-7
• Synonyms：
  mPEG-DTA
  Methoxypoly(ethylene glycol) ditetradecylacetamide
  
• Purity：
  ≥95%
• Recommended Storage Condition：
  Store at -5°C,keep in dry and avoid sunlight.
• Uses：
  Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

mPEG-N,N-Ditetradecylacetamide, also called ALC-0159, mPEG-DTA, is a PEG/lipid conjugate (i.e. PEGylated lipid).  According to public information,  mPEG-DTA (ALC-0159) is one of the excipients of Pfizer's COVID-19 mRNA vaccine.

Biopharma PEG offers a wide range of PEG products from lab to commercial scale in both non-GMP and GMP grades. Besides PEG lipids, we can also provide helper lipids, such as cholesterol (plant-derived), and DSPE for your LNP formulation development. Email at sales@biochempeg.com and start using a superior product for your next product R&D project. 

Cited Publications

This PEG derivative has been cited in peer-reviewed scientific publications. Browse the references below to learn more.

1. ​Masatoshi Maeki, Yuto Okada, Shuya Uno, Kaisei Sugiura, Yuichi Suzuki, Kento Okuda, Yusuke Sato, Masao Ando, Hiroyuki Yamazaki, Masaki Takeuchi, Akihiko Ishida, Hirofumi Tani, Hideyoshi Harashima, Manabu Tokeshi, Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices, Applied Materials Today, Volume 31, 2023, 101754, ISSN 2352-9407, https://doi.org/10.1016/j.apmt.2023.101754.

View more publications citing Biopharma PEG products.